Researchers identified proteomic markers for #LymphoidCancer risk up to 10yrs before diagnosis. This large-scale discovery reveals how early molecular signatures like sCD23 can drive risk stratification & #EarlyDetection
rdcu.be/e6GBZ%E2%80%8B
#Proteomics #PrecisionMedicine #Biomarkers #Lymphoma